on 21 Jun 2024
Last Applicant/ Owned by
SAMIL PHARMACEUTICAL CO. LTD.
155 Hyoryeong-ro, Seocho-guSeoul, 06666
KR
Serial Number
2205060 filed on 18th Aug 2022
Registration Number
TMA1240125 registered on 21st Jun 2024
Registration expiry Date
21st Jun 2034Correspondent Address
MCMILLAN LLP
1500 - 1055 WEST GEORGIA STREETP.O. BOX 11117, ROYAL CENTREVANCOUVER
BRITISH COLUMBIA
CA
V6E4N7
Trademark usage description
pharmaceutical preparations for the prevention and treatment of ophthalmic diseases; pharmaceutical preparations for the treatment of brain diseases a Read MoreVienna Information
26 . 11 . 1
One line or one bandUne ligne ou une bande
26 . 11 . 8
Horizontal lines or bandsLignes ou bandes horizontales
26 . 11 . 10
Straight lines or bandsLignes ou bandes droites
27 . 5 . 1
Letters presenting a special form of writingLettres présentant un graphisme spécial
27 . 5 . 11
Letters underlined, overlined, framed or barred by one or more strokesLettres soulignées, surlignées, encadrées ou barrées d'un ou de plusieurs traits
27 . 5 . 8
Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.Lettres liées à un élément figuratif ou contenant un élément figuratif -- Note: Les lettres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet sont classées dans la division 27.3.
11
2205060
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 190 on 21st Jun 2024 | Registration Pending |
Submitted for opposition 42 on 3rd Apr 2024 | Advertised |
Submitted for opposition 26 on 11th Mar 2024 | Approved |
Submitted for opposition 27 on 11th Mar 2024 | Approval Notice Sent |
Submitted for opposition 22 on 5th Mar 2024 | Search Recorded |
Submitted for opposition 15 on 29th Nov 2023 | Correspondence Created |
Submitted for opposition 15 on 10th Nov 2023 | Correspondence Created |
Submitted for opposition 30 on 18th Aug 2022 | Filed |
Submitted for opposition 1 on 18th Aug 2022 | Created |
Submitted for opposition 31 on 18th Aug 2022 | Formalized |